×

Two drugs target 'bad' cholesterol: CEO

7:21 AM ET Wed, 10 June 2015

Regeneron CEO Leonard Schleifer talks about an FDA panel's approval of Sanofi-Regeneron's new cholesterol-lowering drugs.